Clinical trial
Efficacy of Fructose Metabolizing Enzymatic Product Fructosin(R) in Patients With Fructose Malabsorption
NCT00916487 is registered in ClinicalTrials.gov with Sciotec Diagnostic Technologies GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Fructose Metabolizing Enzymatic Product Fructosin(R) in Patients With Fructose Malabsorption
- Lead sponsor
- Sciotec Diagnostic Technologies GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2009
- Completion date
- August 31, 2010
- Enrollment
- 65 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fructose malabsorption